Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2002
10/31/2002US20020160996 Benzofuran substituted by a fused nitrogen-containing heterocyclic ring such as isoindoline; inhibits cytotoxicity of beta-amyloid; Alzheimer's or Parkinson's disease
10/31/2002US20020160501 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
10/31/2002US20020160282 Nonlinear response; electrical communication; mixture of thiophene compound in polymer matrix
10/31/2002CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002CA2445188A1 Arylindenopyridines with pde inhibiting activity
10/31/2002CA2444595A1 Benzimidazolone derivatives
10/31/2002CA2444592A1 Novel azoles having an insecticidal action
10/31/2002CA2444381A1 Novel compounds
10/31/2002CA2444095A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002CA2444036A1 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/30/2002EP1253396A1 Automatic grenade launcher
10/30/2002EP1252889A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives
10/30/2002EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002EP1252156A1 Blockade of voltage dependent sodium channels
10/30/2002EP1252145A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/30/2002EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002EP1252140A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides
10/30/2002EP1252139A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
10/30/2002EP1000172A4 Detection of targets with green fluorescent protein and fluorescent variants thereof
10/30/2002CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002CN1377346A Z-pyrazoline-5-ones
10/30/2002CN1377268A Cell adhesion inhibitors
10/30/2002CN1093539C Process for synthesizing beta-halobutenolide
10/30/2002CN1093535C Imiazole derivative
10/29/2002US6472536 Such as 2-(4-(4-cyclopentyloxybenzyl)phenyl)amino-imidazoline; antinociceptive agents; ip receptor antagonists; treating inflammatory pain
10/29/2002US6472531 Single reaction vessel acylation and deetherification production of crystalline, high purity chemical intermediates for such as pharmaceuticals
10/29/2002US6472529 Viricides
10/29/2002US6472526 Shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in pharmaceutical composition and intermediates
10/29/2002US6472418 Non-peptide NK1 receptors antagonists
10/29/2002US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002US6472413 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
10/29/2002US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002US6472404 HIV protease inhibitors
10/29/2002US6472399 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/29/2002US6472396 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/29/2002US6472392 Triazole compounds and the use thereof as dopamine-D3 -ligands
10/29/2002US6472391 Nitrogen-containing heterocyclic compounds
10/29/2002US6472386 Cyclic diamine compound with 5-membered ring groups
10/29/2002CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/28/2002WO2001082909A2 2-acyl indol derivatives and their use as anti-tumour agents
10/28/2002CA2407677A1 2-acyl indol derivatives and their use as anti-tumour agents
10/24/2002WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002WO2002083666A1 Substituted benzofuran-2-carboxamides derivatives
10/24/2002WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002WO2002083645A1 Novel compounds
10/24/2002WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002WO2002083629A1 Bissulfonamide derivatives as inhibitors of dehydroquinate synthetases and type ii dehydroquinases
10/24/2002WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002WO2002083622A2 Novel aminophenyl ketone derivatives
10/24/2002WO2002083123A1 Aurones as telomerase inhibitors
10/24/2002WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002WO2002066035A3 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/24/2002WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002WO2002030897A3 Compositions and methods for regulating the nervous system
10/24/2002WO2002014305A3 Design and synthesis of advanced nlo materials for electro-optic applications
10/24/2002WO2002000650A3 Novel compounds possessing antibacterial, antifungal or antitumor activity
10/24/2002US20020156283 Psychological disorders; side effect reduction
10/24/2002US20020156281 Anticholesterol agents; cardiovascular disorders; antilipemic agents; restenosis; dietetics
10/24/2002US20020156276 Nitrogen-containing heterocyclic compounds and therapeutic agents for hyperlipidemia comprising the same
10/24/2002US20020156115 Pyrazolylacetic acid derivatives
10/24/2002US20020156111 Substituted bicyclic compounds
10/24/2002US20020156098 Antiprotozoa agents, parasiticides
10/24/2002US20020156076 Imidazole derivatives used to reduce ocular pressure or treat glaucoma and other diseases
10/24/2002US20020156054 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/24/2002US20020156018 Treating parasitic diseases, which are mediated by such proteases. In particular, treating malaria by inhibiting the cysteine protease falcipain.
10/24/2002DE10119423A1 New cyanoimino- or nitroimino-substituted azole derivatives or analogs, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents
10/24/2002DE10119204A1 Production of new or known 5-aryl-1,3,3-trimethyl-2-methylene-indoline derivatives useful in compositions for dyeing keratin and other fibers, especially human hair
10/24/2002DE10108481A1 Pyridylpyrimidine Pyridylpyrimidines
10/24/2002CA2490819A1 Compounds useful as anti-inflammatory agents
10/24/2002CA2444596A1 Large conductance calcium-activated k channel opener
10/24/2002CA2443699A1 Phenyl heterocyclyl ether
10/24/2002CA2443697A1 1,4-disubstituted benzo-fused compounds
10/24/2002CA2443487A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002CA2441274A1 Aurones as telomerase inhibitors
10/23/2002EP1251127A1 Novel sidechain-bearing taxanes and intermediates thereof
10/23/2002EP1250336A1 Piperidine derivatives and their use as serotonin receptor antagonists
10/23/2002EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002EP1250047A2 Herbicidal composition
10/23/2002EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002EP1073642B1 The use of dihydropyrimidines as medicaments, and novel substances for the treatment of hepatitis b
10/23/2002EP0979229B1 2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors
10/23/2002EP0923561B1 Heterocyclic metalloprotease inhibitors
10/23/2002EP0869947B1 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/23/2002EP0674630B1 7-HALO- AND 7$g(b),8$g(b)-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
10/23/2002CN1376154A Piperidine derivatives as serotonine reuptake inhibitors
10/23/2002CN1376153A Amide compounds
10/23/2002CN1376147A 吡唑类衍生物 Pyrazole derivatives
10/23/2002CN1093128C Process for preparing eprosartan
10/22/2002US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002US6469043 Antiangiogenic agent with antitumor, antimetastatic properties which shows high safety
10/22/2002US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002US6469032 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
10/22/2002US6469029 Azacycloalkanone serine protease inhibitors
10/22/2002US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
10/22/2002US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002US6469011 Benzenesulfonamide compounds useful as TXA2 and 5-HT2 receptor antagonists
1 ... 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 ... 523